You are here: Home / News & Events / News

News

NORD Issues Statement on Departure of FDA Commissioner Margaret Hamburg
February 11, 2015 - NORD President and CEO, Peter L. Saltonstall, has issued a statement following the announcement FDA Commissioner Margaret Hamburg, M.D., will leave her job at the end of March.
NORD Issues Statement on 21st Century Cures Discussion Draft
January 28, 2015 - Peter L. Saltonstall, President and CEO of NORD, issued the following statement after the release of a discussion document by the House Energy and Commerce Committee for its 21st Century Cures initiative.
NORD Awards New Grants for Rare Disease Research
January 9, 2015 - Latest grants continue NORD’s 26-year tradition of promoting life sciences research in rare diseases.
Rep. Waxman & FDA Commissioner Hamburg to Speak at NORD Summit
Washington, D.C., Sept. 25, 2014 - Congressman Henry Waxman and FDA Commissioner Margaret Hamburg will speak at NORD Summit in October.
NORD Urges FDA to Consider Rare Disease Treatment Implications When Setting Biologics Naming Policy
June 4, 2014 - NORD urges FDA Commissioner Hamburg to consider concerns of rare disease community when setting policy regarding names for biologics and biosimilars.
National Organization for Rare Disorders to Honor Two Members of Congress, Patient Advocates and Orphan Product Innovators
April 1, 2014 - NORD to Present Awards at “Portraits of Courage” Celebration on May 8th in Washington, DC.
NORD Opposes Congressman Camp’s Proposed Repeal of Orphan Drug Tax Credit, Says It Threatens Health of People with Rare Diseases
February 27, 2014 - A statement issued today by Peter L. Saltonstall, President and CEO of NORD, opposes repeal of Orphan Drug Tax Credit.
NORD Commends Expansion of SSA’s “Compassionate Allowances” List
January 15, 2014 - People with rare diseases often experience devastating financial challenges, NORD president says.
More Than 100 Rare Disease Patient Organizations and Medical Experts Join NORD in Urging Congress to End the Shutdown
October 11, 2013 - Delays in vital medical research and development of therapies harm children and adults with rare diseases.
NORD Publishes New Online Physician’s Guide to Gaucher Disease
September 4, 2013 - Guides are produced by NORD to promote earlier diagnosis and treatment for patients.

 
Copyright ©2015 NORD - National Organization for Rare Disorders, Inc. All rights reserved.
The following trademarks/registered service marks are owned by NORD: NORD, National Organization for Rare Disorders, the NORD logo, RareConnect. .